drugset / Trial / NCT00260988
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to better understand if either dalteparin or tinzaparin is a better drug to use in dialysis patients on blood thinners who are at high risk of developing blood clots and need surgery.
Timeline
- Start
- 2003-10
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalteparin sodium | Other / unclassified | 5000 iu | Subcutaneous |
| Comparator | Tinzaparin | Other / unclassified | 4500 iu | Subcutaneous |